Infectious Disease Alert – July 1, 2007
July 1, 2007
View Issues
-
The Efficient Diagnosis of Tuberculosis
Brown and colleagues evaluated the most efficient means of microbiological diagnosis of tuberculosis in patients. -
Acinetobacter Infections Associated with Combat Injuries Sustained in Iraq
Since shortly after the return of the first U.S. casualties wounded in Iraq in early 2003 to the United States, significant numbers of infections due to often multidrug-resistant Acinetobacter species have been observed in these patients shortly after arriving back in tertiary care military hospitals in the continental U.S. (CONUS). -
Structural Basis for Coreceptor Selectivity By the HIV Type 1 V3 Loop
Over the last 15 years increased understanding of the complicated process of HIV attachment and entry into host cells has developed. -
Screening for Abacavir Hypersensitivity
The immune response to HIV exerts a selective pressure, just as do antiretroviral drugs. Cytotoxic T lymphocytes (CTL) that recognize HLA class I-restricted viral epitopes expressed on the surface of infected cells exert a pressure on these epitopes. -
Treatment for Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children
A typical mycobacteria are the most common cause of chronic cervicofacial lymphadenitis in children. -
Clinical Manifestations of HTLV-1 Infection
This was a retrospective small case control study that looked at 115 HTLV-1 infected patients from the state of Bahia in Northeastern Brazil who were originally found to be HTLV-1 infected at the time of blood donation and were later followed in a special clinic. -
New Insights: Pandemic and Non-Pandemic Influenza
Why do people die with influenza? three new articles seemingly disparate relate to this age-old question. -
Updates By Carol A. Kemper, MD, FACP
Cases of coccidioidomycosis in the desert states have increased substantially in the past few years, but Arizona has been the hardest hit, with a record number of 5493 cases in 2006. -
Pharmacology Watch: Avandia, Risk of Congestive Heart Failure Significant Safety Risk
Aspirin, Higher Doses No More Effective, Risky; Subclinical Hypothyroidism Treatment Benefits; FDA approvals -
Clinical Briefs in Primary Care supplement